Could a pill replace hospital infusions for leukemia patients?
NCT ID NCT07296445
Summary
This study is testing if a new pill form of arsenic trioxide works as well as the standard intravenous (IV) infusion for treating a specific type of leukemia called acute promyelocytic leukemia (APL). The goal is to see if the pill is absorbed similarly, is safe, and controls the cancer as effectively, which could allow patients to spend less time in the hospital. It will involve about 120 teens and adults who have already completed initial treatment with IV arsenic and another oral drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.